Literature DB >> 17173829

[Mycobacterium marinum infection. Case report and review of the literature].

C R García Acebes1, L Barchino Ortiz, S Aboín González, B Díaz Ley, P Ruiz Fernández, F Sánchez de Paz.   

Abstract

Atypical mycobacterial infections are increasingly important in immunosuppressed patients as well as in healthy hosts. The atypical mycobacterium that most commonly affects the skin is Mycobacterium marinum. The infection should be suspected upon the presence of ulcers, nodules or chronic plaques and a history of contact with fresh or salt water. Optimal therapy is yet to be established. We report a case of Mycobacterium marinum infection in a patient receiving immunosuppressive therapy that responded favourably to treatment with doxicycline. We review the different antibiotic regimens prescribed in the past years for the treatment of Mycobacterium marinum infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173829     DOI: 10.1016/s0001-7310(06)73488-3

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  3 in total

1.  Mycobacterium marinum infection: a case report.

Authors:  Christiane Salgado Sette; Patrick Alexander Wachholz; Paula Yoshiko Masuda; Renata Borges Fortes da Costa Figueira; Fernanda Rodrigues de Oliveira Mattar; Deise Godoy Ura
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-03-20

2.  Mycobacterial Tenosynovitis After Sea Urchin Spine Injury in an Immunocompromised Patient.

Authors:  Christina R Vargas; Anubhav Kanwar; Khalid M Dousa; Marion J Skalweit; David Rowe; James Gatherwright
Journal:  Open Forum Infect Dis       Date:  2018-11-02       Impact factor: 3.835

3.  Mycobacterium marinum infection simulating chromomycosis: a case report.

Authors:  Guilherme Holanda Bezerra; Monica Larissa Padilha Honório; Vivianne Lira da Camara Costa; Hareton Teixeira Vechi; Manoella do Monte Alves; Maria Helena Marques Fonseca de Britto; Keyla Borges Ferreira Rocha; Luciana Distásio de Carvalho
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-11-27       Impact factor: 1.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.